Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function

NCT00076687 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00076687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00076687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
Lead sponsor
Allergan
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2003
Completion date
August 31, 2009
Enrollment
155 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

motor neuron disease, muscle spasticity, stroke